Clinical Trial Update: Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of lemborexant on motor-sleep comorbidity in Parkinson's disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Parkinson Disease

Drugs mentioned

• Lemborexant (lemborexant)

Snippet

Sponsor: YangPan | Conditions: Parkinson's Disease, Insomnia | Phase 4 | Status: RECRUITING